genomiQa brings precision whole-genome analytics to routine clinical practice. We are developing two diagnostics:

CapeDx: Helping clinicians select the best treatment for cancer patients. CapeDx is the most comprehensive cancer genomic test in the world. Available now for research, NATA accreditation for Australia expected mid-2020.

GulfDx: Simplifying the diagnostic odyssey. Whole-genome analysis and clinical reporting to help patients and their families quickly diagnose potential genetic diseases. Available now for research, NATA accreditation for Australia expected late-2020.

genomiQa Pty Ltd

Org chart

Teams

Offices